Verve Therapeutics
VERV
#6947
Rank
ยฃ0.38 B
Marketcap
ยฃ4.50
Share price
-7.99%
Change (1 day)
-58.44%
Change (1 year)

Revenue for Verve Therapeutics (VERV)

Revenue in 2024 (TTM): ยฃ18.96 Million

According to Verve Therapeutics's latest financial reports the company's current revenue (TTM ) is ยฃ19.83 Million. In 2023 the company made a revenue of ยฃ9.22 Million an increase over the revenue in the year 2022 that were of ยฃ1.6 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Verve Therapeutics from 2020 to 2024

202120222023ยฃ5Mยฃ10Mยฃ15Mยฃ20M0companiesmarketcap.com

Annual revenue

Year Revenue Change
2024 (TTM) ยฃ18.96 M105.51%
2023 ยฃ9.22 M475.24%
2022 ยฃ1.6 M
2021 N/A
2020 N/A